| Early Phase II Trials for Cocaine Medication Development - 1 (NCT00000317) | New York State Psychiatric Institute | 1996-08-01 |
| Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2 (NCT00000316) | National Institute on Drug Abuse (NIDA) | 1996-08-01 |
| Risperidone for the Treatment of Cocaine Dependence - 7 (NCT00000342) | National Institute on Drug Abuse (NIDA) | 1996-07-01 |
| Pemoline in the Treatment of Stimulant Dependence - 5 (NCT00000340) | National Institute on Drug Abuse (NIDA) | 1996-06-01 |
| Infusion Laboratory: Protocol 3 (Risperidone) - 4 (NCT00000339) | National Institute on Drug Abuse (NIDA) | 1996-06-01 |
| Effects of Phenytoin on Cocaine Use in Humans - 2 (NCT00000285) | National Institute on Drug Abuse (NIDA) | 1996-05-01 |
| Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4 (NCT00000301) | University of California, Los Angeles | 1996-03-01 |
| Infusion Laboratory: Protocol 2 (Lisuride) - 3 (NCT00000338) | National Institute on Drug Abuse (NIDA) | 1996-03-01 |
| Dose Response Trial of Pergolide for Cocaine Dependence - 1 (NCT00000248) | Medical University of South Carolina | 1996-02-01 |
| Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2 (NCT00000310) | National Institute on Drug Abuse (NIDA) | 1996-01-01 |
| Brain Imaging: Cocaine Effects & Medication Development - 5 (NCT00000270) | New York State Psychiatric Institute | 1995-12-30 |
| Pergolide Treatment for Substance Abusers - 4 (NCT00000269) | National Institute on Drug Abuse (NIDA) | 1995-10-01 |
| Dextroamphetamine-Cocaine Behavioral Intervention - 5 (NCT00000308) | National Institute on Drug Abuse (NIDA) | 1995-09-01 |
| Cocaine Abuse and Attention Deficit Disorder - 3 (NCT00000268) | National Institute on Drug Abuse (NIDA) | 1995-05-01 |
| Naltrexone in Treatment of Cocaine Dependence - 5 (NCT00015080) | National Institute on Drug Abuse (NIDA) | 1995-05-01 |
| Relapse Patterns in Female Cocaine Users - 4 (NCT00000287) | National Institute on Drug Abuse (NIDA) | 1995-02-01 |
| Combining Behavioral Treatment With Agonist Maintenance - 1 (NCT00000311) | Yale University | 1995-02-01 |
| Selegiline in Outpatient Treatment for Cocaine Dependence - 1 (NCT00000336) | National Institute on Drug Abuse (NIDA) | 1995-01-01 |
| New Approaches to Cocaine Abuse Medications (A) - 6 (NCT00000271) | New York State Psychiatric Institute | 1995-01-01 |
| Infusion Laboratory: Protocol 1 - Selegeline - 2 (NCT00000337) | National Institute on Drug Abuse (NIDA) | 1994-11-01 |
| Pharmacotherapy for Schizophrenic Drug Users - 6 (NCT00000281) | Yale University | 1994-09-01 |
| Pemoline for Cocaine Abuse - 7 (NCT00000282) | Yale University | 1994-09-01 |
| Mazindol for Cocaine Abuse - 2 (NCT00000277) | Yale University | 1994-09-01 |
| Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 (NCT00000276) | Yale University | 1994-09-01 |
| Disulfiram for Cocaine-Alcohol Abuse - 3 (NCT00000278) | Yale University | 1994-09-01 |
| Glutaminergic Agents for Cocaine Abuse - 5 (NCT00000280) | Yale University | 1994-09-01 |
| Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 (NCT00000306) | National Institute on Drug Abuse (NIDA) | 1994-09-01 |
| M-CPP and Fenfluramine in Cocaine Addicts - 3 (NCT00000314) | National Institute on Drug Abuse (NIDA) | 1994-09-01 |
| Selegiline in Treatment of Cocaine Dependence - 2 (NCT00000188) | University of Pennsylvania | 1994-09-01 |
| Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 (NCT00000309) | Butler Hospital | 1994-08-01 |
| Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 (NCT00000266) | National Institute on Drug Abuse (NIDA) | 1994-08-01 |
| Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1 (NCT00000245) | National Institute on Drug Abuse (NIDA) | 1994-05-01 |
| Carbamazepine Treatment of Cocaine Dependence - 1 (NCT00000242) | Medical University of South Carolina | 1992-10-01 |
| Ritanserin in Treatment of Cocaine Dependence - 1 (NCT00000187) | University of Pennsylvania | 1992-07-01 |
| IV Cocaine Abuse: A Laboratory Model - 3 (NCT00000214) | New York State Psychiatric Institute | 1992-01-01 |
| Carbamazepine Treatment for Cocaine Dependence - 5 (NCT00000191) | University of Pennsylvania | 1991-01-01 |
| Cocaine in Parotid Saliva, Blood and Urine - 4 (NCT00000190) | University of Pennsylvania | 1991-01-01 |
| IV Cocaine Abuse: A Laboratory Model - 2 (NCT00000213) | New York State Psychiatric Institute | 1990-04-01 |
| Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 (NCT00000189) | University of Pennsylvania | 1990-01-01 |
| Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 (NCT00000211) | National Institute on Drug Abuse (NIDA) | 1989-09-01 |
| IV Cocaine Abuse: A Laboratory Model - 1 (NCT00000212) | New York State Psychiatric Institute | 1987-07-01 |
| Propranolol for Treatment of Cocaine Addiction - 2 (NCT00000197) | National Institute on Drug Abuse (NIDA) | 1987-01-01 |
| Amphetamine Cocaine Interaction Study - 2 (NCT00000305) | The University of Texas Health Science Center, Houston | |
| Pharmacological Modulation of Cocaine Effects - 1 (NCT00000201) | National Institute on Drug Abuse (NIDA) | |
| IV Cocaine Abuse: A Laboratory Model - 4 (NCT00000215) | National Institute on Drug Abuse (NIDA) | |
| Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 (NCT00000349) | National Institute on Drug Abuse (NIDA) | |
| Predictive Values of Serotonergic Alterations for Outcome - 2 (NCT00000313) | National Institute on Drug Abuse (NIDA) | |
| Piracetam for Treatment of Cocaine Addiction, Phase II - 4 (NCT00000199) | University of Pennsylvania | |
| Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 (NCT00000348) | National Institute on Drug Abuse (NIDA) | |
| Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 (NCT00000216) | Yale University | |
| Psychostimulant Abuse - Novel Treatment Approaches - 1 (NCT00000325) | National Institute on Drug Abuse (NIDA) | |
| Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9 (NCT00015275) | National Institute on Drug Abuse (NIDA) | |
| Pharmacotherapy and Intensive Treatment - 2 (NCT00000218) | National Institute on Drug Abuse (NIDA) | |
| Alterations in Serotonergic Functions in Cocaine Addicts - 1 (NCT00000312) | National Institute on Drug Abuse (NIDA) | |
| Risperidone Treatment in Dually-Diagnosed Individuals - 2 (NCT00000267) | National Institute on Drug Abuse (NIDA) | |